Drugs / MM09 Mannosylated
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02661854 | Jun 2016 → Jul 2020 | rhinitis | Inmunotek S.L. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MM09 Mannosylated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02661854 ↗ |
| Route | Subcutaneous | “allergen extract with a concentration of 5.000 MTU (Mannosylated Therapeutic Units)/ml subcutaneous” NCT02661854 ↗ |